These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34802106)

  • 21. ASO Author Reflections: How Should a Surgeon Care and Manage Cancer Metastasis?
    Zhang X; Li TS
    Ann Surg Oncol; 2020 Apr; 27(4):1075-1076. PubMed ID: 31832918
    [No Abstract]   [Full Text] [Related]  

  • 22. ASO Author Reflections: Tailoring Axillary Surgery After Neoadjuvant Endocrine Therapy for Breast Cancer.
    Kantor O; King TA
    Ann Surg Oncol; 2021 Mar; 28(3):1368-1369. PubMed ID: 33389297
    [No Abstract]   [Full Text] [Related]  

  • 23. ASO Author Reflections: Preoperative Prediction of Postmastectomy Radiation Therapy After Neoadjuvant Systemic Therapy.
    Samiei S; Smidt ML; van Nijnatten TJA
    Ann Surg Oncol; 2019 Nov; 26(12):3910-3911. PubMed ID: 31485820
    [No Abstract]   [Full Text] [Related]  

  • 24. ASO Author Reflections: The Pursuit of Eliminating Surgery after Neoadjuvant Systemic Therapy in Breast Cancer Patients.
    van Loevezijn AA; van Duijnhoven FH; Vrancken Peeters MTFD
    Ann Surg Oncol; 2021 Jun; 28(6):3254-3255. PubMed ID: 33301068
    [No Abstract]   [Full Text] [Related]  

  • 25. ASO Author Reflections: Is There a Re-invigorated Role for Melanoma Metastasectomy in a Checkpoint Blockade Era?
    Bello DM; Ariyan CE
    Ann Surg Oncol; 2020 Apr; 27(4):1189-1190. PubMed ID: 31953700
    [No Abstract]   [Full Text] [Related]  

  • 26. ASO Author Reflections: Clinical Benefit of Neoadjuvant Short-Course Radiotherapy for Upper-Third Rectal Tumors over Surgery Alone.
    Flanagan M; Clancy C; Burke J
    Ann Surg Oncol; 2021 Sep; 28(9):5250-5251. PubMed ID: 33782799
    [No Abstract]   [Full Text] [Related]  

  • 27. ASO Author Reflections: Role of Genomic Assay to Predict Neoadjuvant Chemotherapy Response in Breast Cancer.
    Pease AM; James TA
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):573-574. PubMed ID: 30783852
    [No Abstract]   [Full Text] [Related]  

  • 28. ASO Author Reflections: Rate of Axillary Lymph Node Dissection has Decreased in Patients Treated with Neoadjuvant Systemic Therapy.
    Nguyen TT; Boughey JC
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):693-694. PubMed ID: 30421050
    [No Abstract]   [Full Text] [Related]  

  • 29. ASO Author Reflections: Ultrasound-Guided Restaging and Localization of Axillary Lymph Nodes After Neoadjuvant Chemotherapy.
    Kim WH; Kim HJ
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):644-645. PubMed ID: 30315382
    [No Abstract]   [Full Text] [Related]  

  • 30. ASO Author Reflections: Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma Lessens the Deleterious Effect of Omission of Adjuvant Chemotherapy.
    Adam MA; Paniccia A
    Ann Surg Oncol; 2021 Jul; 28(7):3808-3809. PubMed ID: 33475885
    [No Abstract]   [Full Text] [Related]  

  • 31. ASO Author Reflections: Changes in Use of Neoadjuvant Chemotherapy Over Time-Highest Rates of Use Now in Triple-Negative and HER2+ Disease.
    Murphy BL; Boughey JC
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):695-696. PubMed ID: 30465221
    [No Abstract]   [Full Text] [Related]  

  • 32. ASO Author Reflections: Combining Intensive Neoadjuvant Therapy with Minimally Invasive Surgery: A Promising Future Strategy for Rectal Cancer with High-Risk Features.
    Konishi T; Shinozaki E
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):753-754. PubMed ID: 31571051
    [No Abstract]   [Full Text] [Related]  

  • 33. ASO Author Reflections: Elimination of Breast Cancer Surgery in Complete Responders After Neoadjuvant Chemotherapy: Imaging Perspective.
    Rauch GM
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):628-629. PubMed ID: 30244417
    [No Abstract]   [Full Text] [Related]  

  • 34. ASO Author Reflections: Adjuvant Treatment of Melanoma in the Modern Era.
    Rauwerdink DJW; Boland GM
    Ann Surg Oncol; 2020 Dec; 27(13):5137-5138. PubMed ID: 32468350
    [No Abstract]   [Full Text] [Related]  

  • 35. ASO Author Reflections: Association Between Neoadjuvant Chemoradiotherapy and Intractable Serous Ascites After Pancreaticoduodenectomy for Pancreatic Cancer.
    Tomioka A; Uchiyama K
    Ann Surg Oncol; 2021 Jul; 28(7):3798-3799. PubMed ID: 33236253
    [No Abstract]   [Full Text] [Related]  

  • 36. ASO Author Reflections: The Influence of Surgeon Characteristics on Patient-Centered Approaches to Treatment Decision-Making.
    Palmer Kelly E; Tsilimigras DI; Paredes AZ; Pawlik TM
    Ann Surg Oncol; 2020 Jul; 27(7):2157-2158. PubMed ID: 32314158
    [No Abstract]   [Full Text] [Related]  

  • 37. ASO Author Reflections: Gene Expression-Profiling and Implications for Adjuvant Therapy in Melanoma.
    Farrow NE; Beasley GM
    Ann Surg Oncol; 2021 Jul; 28(7):3511. PubMed ID: 33481125
    [No Abstract]   [Full Text] [Related]  

  • 38. ASO Author Reflections: Intensified Neoadjuvant Chemoradiotherapy Followed by Esophagectomy in Esophageal Cancer.
    Boers J; de Groot JWB
    Ann Surg Oncol; 2020 May; 27(5):1529. PubMed ID: 32112209
    [No Abstract]   [Full Text] [Related]  

  • 39. ASO Author Reflections: When to Operate Following Neoadjuvant Therapy for Locally Advanced Rectal Cancer?
    Roxburgh CSD; Weiser MR
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):680-681. PubMed ID: 31392527
    [No Abstract]   [Full Text] [Related]  

  • 40. ASO Author Reflections: Lymph Node Ratio After Neoadjuvant Chemotherapy in Locally Advanced Esophageal Cancer.
    Kano K; Yamada T; Ogata T; Oshima T
    Ann Surg Oncol; 2021 Dec; 28(13):8473. PubMed ID: 34196860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.